The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined FDG and NaF PET/CT study in patients (pts) with metastatic genitourinary tumors (mGU) treated with cabozantinib + nivolumab +/- ipilimumab (CaboNivo+/-Ipi).
 
Jeffrey Lin
No Relationships to Disclose
 
Amir Mortazavi
Leadership - Genentech
 
Mark N. Stein
Research Funding - Abbvie (Inst); Advaxis (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Oncoceutics (Inst)
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Exelixis; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Nicole N. Davarpanah
No Relationships to Disclose
 
Rosa Maria Nadal
No Relationships to Disclose
 
Deneise C Francis
No Relationships to Disclose
 
Marilise Anne Berniger
No Relationships to Disclose
 
Paul Monk
Consulting or Advisory Role - Bayer; Lilly
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Prometheus
Travel, Accommodations, Expenses - Lilly
 
Jeffrey Kempf
No Relationships to Disclose
 
Murray Becker
No Relationships to Disclose
 
Levi Sokol
No Relationships to Disclose
 
Yolanda McKinney
No Relationships to Disclose
 
Michael V. Knopp
No Relationships to Disclose
 
Chadwick Wright
No Relationships to Disclose
 
Alex Jung
No Relationships to Disclose
 
Peter L. Choyke
Patents, Royalties, Other Intellectual Property - I am a patent holder for MRI-Ultrasound fusion technology licensed to InVivo which markets it as UroNav. However, as a government employee I personally receive no financial benefit from this patent.
 
Esther Mena
No Relationships to Disclose
 
Liza Lindenberg
No Relationships to Disclose
 
Andrea B. Apolo
No Relationships to Disclose